abstract |
The present invention relates to a macrocycle containing aminopyrazole and pyrimidine, which is represented by formula (I), a pharmaceutical composition thereof, and a use thereof in inhibiting the activity of tropomyosin-linked receptor kinase (Trk) as well as Trk-mediated diseases in mammals. |